Four Additional Awards to Prevent Opioid Misuse Among Women and Girls
As part of the administration’s efforts to combat the opioid epidemic, the U.S. Department of Health and Human Services (HHS) Office on Women’s Health (OWH) made four additional awards to prevent opioid misuse among women and girls. Like the previous awards, the four new awards support the primary and/or secondary prevention of prescription and illegal opioid misuse by women across the lifespan.
The four organizations each receiving awards of approximately $100,000 are:
To learn more about the impact of the opioid epidemic on women, read OWH’s report.
The U.S. Preventive Services Task Force (USPSTF) Seeks Comments
The USPSTF seeks comments on screening for cervical cancer. The Task Force recommends screening most women 21 to 65 for cervical cancer. The draft recommendation statement and draft evidence review are available for review and public comment until October 9, 2017.
The Centers for Disease Control and Prevention Updates U.S. Medical Eligibility Criteria for Contraceptive Use (U.S. MEC)
Use of progestin-only injectable contraceptives (including depot medroxyprogesterone acetate) by women at high risk for HIV has been changed from a U.S. MEC category 1 (safe for use without restriction) to U.S. MEC category 2 (benefits outweigh theoretical or proven risks). Read the full report.
Tools and Resources for Patient Engagement
Visit the Printables and Shareables section of the OWH website for tools and resources that were designed to be easily downloaded, printed, and shared with patients. Use them to start conversations around health topics, inform your patients, and encourage informed shared decision-making. Health information can be found by topic or publication type. Find fact sheets, infographics, guides, videos, and webinars on a variety of health topics that impact women and girls.